Chemokine C-X-C-Motif Receptor 3 (CXCR3) Antibody (FITC)

Este producto es parte de CXCR - C-X-C motif chemokine receptor
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Chemokine C-X-C-Motif Receptor 3 (CXCR3) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx312668

Description

CXCR3 Antibody (FITC) is a Rabbit Polyclonal against CXCR3 conjugated to FITC.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Chemokine C-X-C-Motif Receptor 3 (CXCR3)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P49682
Gene ID
2833
NCBI Accession
NP_001136269.1, NM_001142797.1, NP_001495.1, NM_001504.1
OMIM
300574
Alias
CXCR3,GPR9,MigR,CD182,CD183,Mig-R,CKR-L2,CMKAR3,IP10-R,G protein-coupled receptor 9,CXC-R3,interferon-inducible protein 10 receptor,IP-10 receptor
Background
Antibody anti-CXCR3
Status
RUO

Descripción

CXCR3 is a G protein-coupled receptor (GPCR) primarily expressed on activated T cells, natural killer (NK) cells, and some epithelial cells. It binds chemokines such as CXCL9, CXCL10, and CXCL11, which are induced by interferon-gamma during inflammation. CXCR3 plays a critical role in T cell trafficking, promoting migration to inflammatory sites and tumor microenvironments. Its activation triggers signaling pathways like PI3K, MAPK, and JAK/STAT, leading to cell migration, proliferation, and cytokine production. CXCR3 has two main isoforms, CXCR3-A and CXCR3-B, which mediate different functions: CXCR3-A drives chemotaxis and immune cell recruitment, while CXCR3-B can induce apoptosis and inhibit cell migration under specific conditions. CXCR3 is implicated in autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease, where aberrant T cell migration leads to chronic inflammation. In cancer, CXCR3 regulates both pro- and anti-tumor responses; while it facilitates immune cell infiltration into tumors, it can also enhance tumor cell metastasis and angiogenesis in some cancers. Its expression in tumor cells has been linked to poor prognosis, particularly in melanoma, breast, and lung cancers. Pharmacological targeting of CXCR3 is being explored to modulate immune responses, reduce inflammation, and improve cancer immunotherapy. Overall, CXCR3 is essential for immune cell migration, balancing immune surveillance and disease progression.

Related Products

APC-30064

APC Anti-Human CD183(G025H7)

Ver Producto
EH0982

Human CXCR3 (C-X-C chemokine receptor type 3) ELISA Kit

Ver Producto
EM0968

Mouse CXCR3 (CXC-chemokine receptor 3) ELISA Kit

Ver Producto